<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01483430</url>
  </required_header>
  <id_info>
    <org_study_id>CJ_Ginseol Kg1</org_study_id>
    <nct_id>NCT01483430</nct_id>
  </id_info>
  <brief_title>Effect of Ginseol Kg1 on Blood Pressure Lowering</brief_title>
  <official_title>Effect of Ginseol Kg1 on Blood Pressure Lowering in Prehypertensive or Stage I Hypertensive Patients: Multicenter, Randomized, Placebo-controlled, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DongGuk University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we investigate the effects of Ginseol Kg1 (Korea red ginseng extract) on blood
      pressure in prehypertensive or stage I hypertensive patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, randomized, placebo-controlled, double-blind study. At the end of an
      initial 2-week washout period, patients fulfilling the inclusion criteria are assigned to
      three groups, i.e. control group (placebo), low dose Ginseol Kg1 group (100mg), or high dose
      Ginseol Kg1 (300mg) group. They will intake the study drug for 8 weeks. 24-h ambulatory BP
      monitoring (ABPM) and pulse wave velocity are measured at the end of the washout period and
      after 8 weeks of active treatment. At each visit, seated SBP and DBP, heart rate, use of
      concomitant medication and spontaneously reported adverse events are recorded. Compliance
      with medication (determined by counting returned tablets) is evaluated at each visit.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference of the changes in office diastolic and systolic BP after 8 weeks' treatment between placebo and Ginseol Kg1 group</measure>
    <time_frame>baseline and 8 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference of the changes in the mean 24-hour ambulatory systolic and diastolic BP after 8 weeks' treatment between placebo and Ginseol Kg1 group.</measure>
    <time_frame>baseline and 8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference of the change in the brachial-ankle pulse wave velocity after 8 weeks' treatment between placebo and Ginseol Kg1 group.</measure>
    <time_frame>baseline and 8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference of the change in the hs-CRP after 8 weeks' treatment between placebo and Ginseol Kg1 group.</measure>
    <time_frame>baseline and 8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference of the change in the lipid profiles after 8 weeks' treatment between placebo and Ginseol Kg1 group</measure>
    <time_frame>baseline and 8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference of the changes in office diastolic and systolic BP after 4 weeks' treatment between placebo and Ginseol Kg1 group.</measure>
    <time_frame>baseline and 4 week</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Prehypertension</condition>
  <condition>Hypertension, Stage I</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ginseol Kg1, high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ginseol Kg1, low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginseol Kg1 (low dose)</intervention_name>
    <description>1 capsule/day (100mg of Ginseol Kg1), Duration: 8 weeks</description>
    <arm_group_label>Ginseol Kg1, low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginseol Kg1(high dose)</intervention_name>
    <description>1 capsule/day (300mg of Ginseol Kg1), Duration: 8 weeks</description>
    <arm_group_label>Ginseol Kg1, high dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 capsule/day (starch), Duration: 8 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: Adults over 20 years

          -  Prehypertension or stage 1 hypertension (systolic blood pressure 120~159mmHg or
             diastolic blood pressure 80~99mmHg)

          -  Subject who has not taken medications to treat hypertension within 15 days prior to
             first visit

        Exclusion Criteria:

          -  Subject who has been involved in other clinical trials within 30 days prior to first
             visit

          -  Subject who has following diseases within 2 years prior to screening: angina pectoris,
             myocardial infarction, heart failure, peripheral vascular disease, chronic liver
             failure, chronic renal failure, diabetes mellitus, hyperthyroidism, hypothyroidism,
             malignant tumor, mental disease

          -  Systolic blood pressure ≥ 160mmHg or diastolic blood pressure ≥ 100 mmHg during
             screening period

          -  Subject who has hepatic dysfunction(AST, ALT ≥ 2.5 times higher than normal value)

          -  Subject who has renal dysfunction(creatinine ≥ 1.5 times higher than normal value)

          -  Subject who is pregnant or breast feeding

          -  Alcoholic

          -  Subject who has an allergy to the ingredients of study product
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kwang-il Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kwang-il Kim, MD, PhD</last_name>
    <phone>+82-31-787-7032</phone>
    <email>kikim907@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kwang-il Kim, MD, PhD</last_name>
      <phone>+82-31-787-7032</phone>
      <email>kikim907@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2011</study_first_submitted>
  <study_first_submitted_qc>November 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2011</study_first_posted>
  <last_update_submitted>November 30, 2011</last_update_submitted>
  <last_update_submitted_qc>November 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kwang-il Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Blood pressure</keyword>
  <keyword>Korea red ginseng</keyword>
  <keyword>Ambulatory blood pressure</keyword>
  <keyword>Pulse wave velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prehypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

